Request for Comments on the Draft Administrative Order entitled “Implementing Guidelines on the Procurement and Reimbursement of Essential Medicines (Capsules and Tablets) under the Philippine National Formulary (PNF)”
Since its inception in 1988, the PNF has played a critical role in promoting the rational selection, procurement, use, and reimbursement of medicines in the country. Improvements to the essential medicine list are continuously being undertaken to fine-tune and align itself with the current need of the populace.

The Pharmaceutical Division, as its custodian, receives requests for clarification from stakeholders relative to the molecules, formulations, technical specifications, and defined terms within the PNF. For purposes of clarity, this Office deems it necessary to provide uniform guidance in the interpretation of the above-cited dosage forms to abate delays in access to essential medicines.

Anent to this, this Office is requesting the concerned stakeholders to review/comment on the draft Administrative Order.

You may access the draft AO and the recommended response template through this link: Click Me.

We hope to receive your comments until 09 December 2022.

For further information, you may reach us at pnf@doh.gov.ph or through Mr. Lorenzo P. Javier at 8651-7800 local 8102.

Thank you and stay safe!
Philippine Antimicrobial Awareness Week 2022
Umayka ta! Agsarita tayo “The 17th Policy Dialogue on Universal Healthcare and Access to Medicines”
Philippine Essential medical Device List
Philippine Medicines Policy 2022-2030
Strategic Framework and Implementing Guidelines of the Philippine Medicines Policy 2022-2030
DOH Showcased “Malasakit at Aksyon” in the 1st face to face Policy Dialogue Since 2019
Program implementation review and updates on the different programs of the pharmaceutical division
Duterte Legacy Summit highlights DOH efforts on setting Maximum Retail Price for high-cost medicines
ASEAN Member States Virtually Assemble in the recent Drug Price Transparency Workshop

The Department of Health (DOH), together with other member agencies of the Inter-Agency Committee on Antimicrobial Resistance (ICAMR), culminated the week-long celebration of the Philippine Antimicrobial Awareness Week (PAAW) highlighting the importance of the One Health approach to combat antimicrobial resistance (AMR) fuelled by the COVID-19 pandemic threat.

//
November 24, 2022

Traversing towards the realization of quality primary healthcare through free access to essential medicines in support to the goals of the Universal Health Care in Region 1, Laoag City hosted the 17th Policy Dialogue on Universal Health Care and Access to Medicines through a Patient Forum at Sola Hotel, Laoag City, 18 November 2022.

//
November 23, 2022

The Philippine Essential Medical Device List (PEMDL) is a compilation of essential medical devices considered as important or necessary for the preventive, diagnostic, therapeutic, or rehabilitative procedures carried out in government health facilities in accordance with Administrative Order No. 2021-0038 “Framework for Philippine Essential Medical Devices List and Price Reference Index”.



Click the title to know more about the PEMDL

//
November 23, 2022

OIC-SOH Singh-Vergeire Leads Launching of National Roadmap to Bolster Local Generics Industry

//
September 30, 2022

Pursuant to the Government’s thrust towards Universal Health Care (UHC) and in light of the major changes in the pharmaceutical landscape, the Department of Health (DOH), through the Pharmaceutical Division (PD), crafted the Philippine Medicines Policy which would be implemented from the years 2022 to 2030 to mobilize all key players in the pharmaceutical sector to implement evidence-based policies, improve sustainability programs and leverage best practices throughout the pharmaceutical supply chain.

//
August 2, 2022

After three long years and five virtual policy dialogues, the Department of Health (DOH), its partner agencies and offices and the patient support groups and civil society organizations finally convened again face to face during the 16th Policy Dialogue on Universal Healthcare and Access to Medicines held on June 9, 2022 at Cocoon Boutique Hotel, Quezon City.

//
June 10, 2022

The Department of Health-Pharmaceutical Division (DOH-PD) conducted a face-to-face Program Implementation Review (PIR) and updates on the different programs of the Pharmaceutical Division in Coron Palawan last April 26-28, 2022 after two years of restrictions from the COVID-19 pandemic.

//
June 1, 2022

The DOH Pharmaceutical Division expresses its gratitude to the leadership and concern for poor and vulnerable Filipino patients shown by President Rodrigo Duterte with the passage of two landmark Executive Orders which set maximum retail price to 120 high cost medicines.

//
June 1, 2022

The Association of Southeast Asian Nations (ASEAN) Member States, comprising Brunei, Cambodia, Indonesia, Laos, Malaysia, Myanmar, Philippines, Singapore, Thailand, and Vietnam, convened in a two-day online workshop to ensure fair prices and effective financing of medicines and health technologies with the aim to fortify health systems and to achieve wider Universal Health Coverage on April 6-7, 2022.

//
April 20, 2022

Advisories

DOH updates list of VAT-Exempt Medicines under RA 11354

The Department of Health (DOH) informed the Bureau of Internal Revenue (BIR) through Commissioner Caesar R. Dulay the revisions to the list of VAT-Exempt Medicines under Republic Act. 11354 or Corporate Recovery and Tax Incentives for Enterprises (CREATE) Act.

Read More »

Events

Philippine Standard time

Contact Us:

Telephone Number: 02-8757734 Loc. 253

Address: 4th Floor, Philippine Blood Center, Lung Center Compound, Quezon Avenue, Quezon City

Email Address: pharmareceiving@doh.gov.ph